Around 60% of Australians with hepatitis C have accessed treatment which usually cures the condition. But to eliminate the disease, we need to prevent re-infection and tackle stigma.
Climate change, inequality, the evolution of knowledge… Experts have been surveyed, and a consensus is emerging on what to expect from the effects of these factors in the medical field.
Using a Nobel Prize-winning technique called cryo-EM, researchers were able to identify potential areas on the hepatitis C virus that a vaccine could target.
Millions of Americans wear jewelry that pierces the ear, nose, lips, tongue and genital areas. But adorning yourself with metal body art can be a health hazard.
Direct-acting antivirals can cure hepatitis C in eight to 12 weeks. But while the rate of uptake in Australia has slowed, a greater proportion of those undertaking treatment are in prison.
Direct-acting antivirals have mostly been used in countries with high incomes. These drugs would be effective against most hepatitis C strains. which are primarily low-income countries.
Michael Houghton, an Edmonton-based virologist, was one of the recipients of this year’s Nobel Prize for physiology or medicine for the discovery of hepatitis C.
The 2020 Nobel Prize for Physiology or Medicine goes to the discoverers of the hepatitis C virus. There’s an effective cure but homelessness and the opioid epidemic are driving a surge in infections.
Proposals in NSW to force someone who spits at or bites a frontline worker to be tested for HIV and other blood-borne viruses are a real problem - for workers and the public.
New research reveals a link between a diagnosis of cancer and a lifetime number of 10 or more sexual partners. But there are some flaws in the research we need to consider in interpreting the results.
Benjamin Cowie, The Peter Doherty Institute for Infection and Immunity; Karen McCulloch, The University of Melbourne, and Nicole Romero, The Peter Doherty Institute for Infection and Immunity
Curing thousands of Australians with hepatitis C is one of the public health success stories of recent years. We can take lessons from this as we continue in the fight against hepatitis B.
As concern grows for the escalating prices of prescription drugs, a novel approach to lower the price of drugs to treat hepatitis C in Louisiana holds promise, a policy expert says.